X |
Filing Date |
Trade Date |
Ticker |
Company Name | Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2025-11-17 | SIBN | Si-Bone, Inc. | Recupero Anthony J | Pres, Commercial Ops | S - Sale | $17.44 | -3,833 | 268,144 | -1% | -$66,832 | ||||||
2025-11-17 | SIBN | Si-Bone, Inc. | Pisetsky Michael A. | SVP, Ops, Adm, Chief Legal Ofr | S - Sale | $17.41 | -3,328 | 251,896 | -1% | -$57,934 | ||||||
2025-11-17 | SIBN | Si-Bone, Inc. | Maheshwari Anshul | CFO | S - Sale | $17.43 | -3,460 | 205,073 | -2% | -$60,297 | ||||||
| M | 2025-11-17 | SIBN | Si-Bone, Inc. | Francis Laura | CEO | S - Sale | $17.51 | -16,752 | 759,682 | -2% | -$293,385 | |||||
2025-11-19 | ARAY | Accuray Inc | La Neve Stephen R. | CEO | P - Purchase | $0.97 | +20,000 | 20,000 | New | +$19,410 | ||||||
2025-11-18 | AORT | Artivion, Inc. | Hoff Elizabeth A | Dir | S - Sale | $45.10 | -4,200 | 27,189 | -13% | -$189,412 | ||||||
2025-11-18 | IRMD | Iradimed Corp | Susi Roger E. | CEO, Pres, COB, 10% | S - Sale | $85.59 | -5,000 | 4,537,950 | 0% | -$427,957 | ||||||
2025-11-18 | SRTS | Sensus Healthcare, Inc. | Sardano Joseph C | CEO | P - Purchase | $4.03 | +25,000 | 1,200,293 | +2% | +$100,750 | ||||||
2025-11-18 | SRTS | Sensus Healthcare, Inc. | Sardano Michael | Pres, GC | P - Purchase | $3.80 | +1,000 | 118,839 | +1% | +$3,800 | ||||||
| D | 2025-11-14 | TNON | Tenon Medical, Inc. | Foster Steven M | CEO, Pres | P - Purchase | $0.00 | +19,455 | 22,878 | +568% | +$0 | |||||
| D | 2025-11-14 | TNON | Tenon Medical, Inc. | Geist Wyatt D. | Chief Innovation Officer | P - Purchase | $0.00 | +19,455 | 508,334 | +4% | +$0 | |||||
| D | 2025-11-14 | TNON | Tenon Medical, Inc. | Grawey Nathaniel A. | Chief Commercial Officer | P - Purchase | $0.00 | +101,167 | 414,664 | +32% | +$0 | |||||
2025-11-17 | SGHT | Sight Sciences, Inc. | Taylor Brenton | EVP, Operations, R, D | S - Sale | $7.06 | -14,418 | 170,831 | -8% | -$101,791 | ||||||
2025-11-17 | SSKN | Strata Skin Sciences, Inc. | Rubinstein Samuel | Dir | S - Sale | $1.33 | -14,094 | 8,766 | -62% | -$18,804 | ||||||
2025-11-18 | SSKN | Strata Skin Sciences, Inc. | Rubinstein Samuel | Dir | P - Purchase | $1.41 | +5,000 | 8,766 | +133% | +$7,028 | ||||||
| A | 2025-11-11 | SRTS | Sensus Healthcare, Inc. | Sardano Michael | Pres, GC | P - Purchase | $4.27 | +2,000 | 118,839 | +2% | +$8,546 | |||||
| DM | 2025-11-14 | AORT | Artivion, Inc. | Holloway Jean F | SVP, GC | S - Sale+OE | $45.09 | -12,787 | 163,408 | -7% | -$576,502 | |||||
| DM | 2025-11-14 | AORT | Artivion, Inc. | Davis John E | Chief Commercial Officer | S - Sale+OE | $44.92 | -12,787 | 198,842 | -6% | -$574,392 | |||||
2025-11-17 | AORT | Artivion, Inc. | Horton Amy | VP, Chief Accounting Officer | S - Sale | $45.73 | -6,000 | 135,380 | -4% | -$274,380 | ||||||
2025-11-14 | DXCM | Dexcom Inc | Collins Richard Alexander | Dir | S - Sale | $59.05 | -2,906 | 40,162 | -7% | -$171,599 | ||||||
2025-11-14 | OBIO | Orchestra Biomed Holdings, Inc. | Hochman David P | See Remarks | P - Purchase | $4.07 | +5,000 | 1,064,727 | 0% | +$20,350 | ||||||
2025-11-17 | TELA | Tela Bio, Inc. | Ew Healthcare Partners Fund 2, L.P. | See Remarks, 10% | P - Purchase | $1.11 | +3,604,000 | 7,714,709 | +88% | +$4,000,440 | ||||||
| D | 2025-11-14 | SYK | Stryker Corp | Berry William E Jr | VP, Chief Accounting Officer | S - Sale+OE | $365.49 | -1,953 | 3,446 | -36% | -$713,802 | |||||
2025-11-14 | RVP | Retractable Technologies Inc | Shaw Thomas J | Pres, CEO, 10% | P - Purchase | $0.77 | +5,731 | 16,662,822 | 0% | +$4,424 | ||||||
| D | 2025-11-12 | SGHT | Sight Sciences, Inc. | Hayden Jeremy B. | GC | S - Sale+OE | $8.01 | -3,150 | 256,590 | -1% | -$25,232 | |||||
| D | 2025-11-13 | MMM | 3M Co | Dickson Zoe L | EVP, CHRO | S - Sale+OE | $169.82 | -13,629 | 6,460 | -68% | -$2,314,538 | |||||
| D | 2025-11-13 | MMM | 3M Co | Dickson Zoe L | EVP, CHRO | S - Sale+OE | $169.78 | -13,826 | 6,460 | -68% | -$2,347,371 | |||||
2025-11-12 | ATEC | Alphatec Holdings, Inc. | Squadron Capital Holdings LLC | 10% | S - Sale | $20.80 | -250,000 | 11,145,045 | -2% | -$5,200,000 | ||||||
2025-11-12 | ATEC | Alphatec Holdings, Inc. | Pritzker Jennifer N. | 10% | S - Sale | $20.80 | -250,000 | 13,965,781 | -2% | -$5,200,000 | ||||||
2025-11-12 | ATEC | Alphatec Holdings, Inc. | Pelizzon David R | Dir, 10% | S - Sale | $20.80 | -250,000 | 11,491,872 | -2% | -$5,200,000 | ||||||
2025-11-12 | ATEC | Alphatec Holdings, Inc. | Squadron Capital LLC | 10% | S - Sale | $20.80 | -250,000 | 11,145,045 | -2% | -$5,200,000 | ||||||
2025-11-13 | AORT | Artivion, Inc. | Horton Amy | VP, Chief Accounting Officer | S - Sale | $45.86 | -3,482 | 141,380 | -2% | -$159,678 | ||||||
2025-11-13 | AORT | Artivion, Inc. | Davis John E | Chief Commercial Officer | S - Sale | $45.86 | -6,563 | 198,842 | -3% | -$300,966 | ||||||
2025-11-13 | AORT | Artivion, Inc. | Mackin James P | Pres, CEO | S - Sale | $45.86 | -34,210 | 800,993 | -4% | -$1,568,802 | ||||||
2025-11-13 | AORT | Artivion, Inc. | Holloway Jean F | SVP, GC | S - Sale | $45.86 | -5,761 | 163,408 | -3% | -$264,188 | ||||||
2025-11-13 | AORT | Artivion, Inc. | Stanton Marshall S. | SVP, Clinical, MD Affair | S - Sale | $45.86 | -4,993 | 56,641 | -8% | -$228,969 | ||||||
2025-11-12 | RMD | Resmed Inc | Farrell Peter C | Dir | S - Sale | $252.05 | -2,000 | 66,110 | -3% | -$504,100 | ||||||
2025-11-11 | RMD | Resmed Inc | De Witte Jan | Dir | S - Sale | $250.25 | -487 | 5,242 | -9% | -$121,872 | ||||||
| D | 2025-11-12 | GMED | Globus Medical Inc | Davidar David D | Dir | S - Sale+OE | $86.00 | -25,000 | 682,242 | -4% | -$2,150,005 | |||||
| M | 2025-11-11 | LYRA | Lyra Therapeutics, Inc. | Perceptive Advisors LLC | 10% | S - Sale | $3.98 | -45,875 | 14,026 | -77% | -$182,515 | |||||
| D | 2025-11-11 | GMED | Globus Medical Inc | Zarrilli Stephen T | Dir | S - Sale+OE | $84.29 | -25,000 | 0 | -100% | -$2,107,258 | |||||
2025-11-11 | SIBN | Si-Bone, Inc. | Francis Laura | CEO | S - Sale | $17.06 | -5,411 | 776,434 | -1% | -$92,307 | ||||||
| D | 2025-11-11 | SIBN | Si-Bone, Inc. | Dunn Jeffrey W | Dir | S - Sale+OE | $18.95 | -80,000 | 129,181 | -38% | -$1,516,000 | |||||
2025-11-11 | SIBN | Si-Bone, Inc. | Maheshwari Anshul | CFO | S - Sale | $18.33 | -2,601 | 208,533 | -1% | -$47,685 | ||||||
2025-11-12 | NSPR | Inspiremd, Inc. | Stuka Paul | Dir | P - Purchase | $1.62 | +13,431 | 817,910 | +2% | +$21,758 | ||||||
2025-11-11 | RVP | Retractable Technologies Inc | Shaw Thomas J | Pres, CEO, 10% | P - Purchase | $0.81 | +100 | 16,657,091 | 0% | +$81 | ||||||
2025-11-11 | DCTH | Delcath Systems, Inc. | Michel Gerard J | CEO | P - Purchase | $8.53 | +11,500 | 330,834 | +4% | +$98,049 | ||||||
| A | 2025-11-11 | SRTS | Sensus Healthcare, Inc. | Sardano Michael | Pres, GC | P - Purchase | $4.26 | +2,000 | 236,678 | +1% | +$8,523 | |||||
| DM | 2025-11-10 | AORT | Artivion, Inc. | Holloway Jean F | SVP, GC | S - Sale+OE | $45.82 | -12,960 | 169,169 | -7% | -$593,872 | |||||
2025-11-10 | AORT | Artivion, Inc. | Mackin James P | Pres, CEO | S - Sale | $44.62 | -17,580 | 835,203 | -2% | -$784,402 | ||||||
2025-11-10 | AORT | Artivion, Inc. | Davis John E | Chief Commercial Officer | S - Sale | $44.62 | -3,373 | 205,405 | -2% | -$150,500 | ||||||
2025-11-10 | AORT | Artivion, Inc. | Horton Amy | VP, Chief Accounting Officer | S - Sale | $44.62 | -1,789 | 144,862 | -1% | -$79,823 | ||||||
2025-11-10 | AORT | Artivion, Inc. | Stanton Marshall S. | SVP, Clinical, MD Affair | S - Sale | $44.62 | -2,566 | 61,634 | -4% | -$114,492 | ||||||
2025-11-10 | PEN | Penumbra Inc | Roberts Johanna | EVP, Gen. Counsel, Secretary | S - Sale | $266.98 | -600 | 63,657 | -1% | -$160,189 | ||||||
2025-11-12 | DXCM | Dexcom Inc | Heller Bridgette P | Dir | S - Sale | $58.07 | -1,012 | 27,031 | -4% | -$58,767 | ||||||
| D | 2025-11-10 | IRTC | Irhythm Technologies, Inc. | Talwalkar Abhijit Y | Dir | S - Sale+OE | $174.13 | -5,312 | 20,299 | -21% | -$924,962 | |||||
2025-11-10 | HAE | Haemonetics Corp | Kroll Mark W | Dir | P - Purchase | $70.56 | +1,400 | 24,757 | +6% | +$98,784 | ||||||
2025-11-10 | IRMD | Iradimed Corp | Susi Roger E. | CEO, Pres, COB, 10% | S - Sale | $85.24 | -5,000 | 4,542,950 | 0% | -$426,193 | ||||||
2025-11-10 | IRMD | Iradimed Corp | Glenn John | CFO | S - Sale | $84.51 | -10,651 | 2,500 | -81% | -$900,162 | ||||||
2025-11-06 | UFPT | Ufp Technologies Inc | Litterio Christopher P. | SVP | S - Sale | $227.20 | -1,829 | 10,756 | -15% | -$415,550 | ||||||
| D | 2025-11-11 | ICUI | Icu Medical Inc/De | Finney Elisha W | Dir | S - Sale+OE | $140.42 | -1,285 | 3,995 | -24% | -$180,440 | |||||
2025-11-11 | ICUI | Icu Medical Inc/De | Sanzone Virginia Ruth | VP, GC | S - Sale | $142.35 | -930 | 5,456 | -15% | -$132,381 | ||||||
2025-11-11 | SRTS | Sensus Healthcare, Inc. | Sardano Michael | Pres, GC | P - Purchase | $4.26 | +1,000 | 117,839 | +1% | +$4,260 | ||||||
2025-11-10 | DXCM | Dexcom Inc | Leach Jacob Steven | Pres, COO | P - Purchase | $55.04 | +18,200 | 378,993 | +5% | +$1,001,702 | ||||||
2025-11-10 | DXCM | Dexcom Inc | Collins Richard Alexander | Dir | S - Sale | $55.17 | -3,948 | 43,068 | -8% | -$217,811 | ||||||
| D | 2025-11-07 | RMD | Resmed Inc | Farrell Michael J. | COB, CEO | S - Sale+OE | $249.75 | -8,011 | 469,956 | -2% | -$2,000,773 | |||||
2025-11-06 | MDXG | Mimedx Group, Inc. | Maersk-Moller Kimberly | Chief Commercial Officer | S - Sale | $7.42 | -58,300 | 236,982 | -20% | -$432,329 | ||||||
2025-11-07 | BVS | Bioventus Inc. | McMurry-Heath Michelle | Dir | S - Sale | $7.42 | -17,701 | 56,997 | -24% | -$131,255 | ||||||
| M | 2025-11-06 | LYRA | Lyra Therapeutics, Inc. | Perceptive Advisors LLC | 10% | S - Sale | $4.89 | -70,390 | 18,659 | -79% | -$344,219 | |||||
| M | 2025-11-07 | GMED | Globus Medical Inc | Rhoads Ann D | Dir | S - Sale | $81.80 | -10,000 | 15,384 | -39% | -$818,000 | |||||
2025-11-07 | SINT | Sintx Technologies, Inc. | Honigblum Gregg R. | Chief Investment Officer | P - Purchase | $3.19 | +10,000 | 74,000 | +16% | +$31,900 | ||||||
2025-11-06 | NXGL | Nexgel, Inc. | Levy Adam R. | CEO | S - Sale | $2.52 | -4,000 | 367,692 | -1% | -$10,084 | ||||||
2025-11-07 | BDX | Becton Dickinson & Co | Scott Bertram L | Dir | S - Sale | $176.58 | -217 | 35,816 | -1% | -$38,318 | ||||||
| M | 2025-11-05 | SYK | Stryker Corp | Stryker Ronda E | Dir | S - Sale | $355.01 | -520,000 | 16,319,726 | -3% | -$184,606,141 | |||||
2025-11-04 | PEN | Penumbra Inc | Grewal Harpreet | Dir | S - Sale | $227.58 | -186 | 8,516 | -2% | -$42,330 | ||||||
2025-11-06 | BSX | Boston Scientific Corp | Zane Ellen M | Dir | S - Sale | $98.28 | -12,891 | 24,134 | -35% | -$1,266,978 | ||||||
2025-11-05 | IART | Integra Lifesciences Holdings Corp | Graves Jeffrey A | Dir | P - Purchase | $11.35 | +9,000 | 41,086 | +28% | +$102,150 | ||||||
2025-11-05 | RVP | Retractable Technologies Inc | Shaw Thomas J | Pres, CEO, 10% | P - Purchase | $0.83 | +7,500 | 16,656,991 | 0% | +$6,195 | ||||||
2025-10-31 | BBNX | Beta Bionics, Inc. | Lezack Adam | Dir | S - Sale | $26.87 | -1,406 | 9,841 | -13% | -$37,780 | ||||||
2025-10-31 | BBNX | Beta Bionics, Inc. | Palasis Maria | Dir | S - Sale | $26.91 | -1,406 | 9,841 | -13% | -$37,834 | ||||||
2025-11-03 | ATEC | Alphatec Holdings, Inc. | Rydin Jeffrey P | Dir | S - Sale | $19.32 | -200,000 | 385,441 | -34% | -$3,864,000 | ||||||
2025-11-03 | ATEC | Alphatec Holdings, Inc. | Miles Patrick | CEO | S - Sale | $18.96 | -100,000 | 5,624,978 | -2% | -$1,896,000 | ||||||
2025-11-04 | PSTV | Plus Therapeutics, Inc. | Sims Andrew John Hugh Macintyre | CFO | P - Purchase | $0.51 | +20,000 | 68,138 | +42% | +$10,200 | ||||||
2025-11-03 | SIBN | Si-Bone, Inc. | Dunn Jeffrey W | Dir | S - Sale | $14.80 | -293 | 129,181 | 0% | -$4,338 | ||||||
2025-11-03 | IRTC | Irhythm Technologies, Inc. | Blackford Quentin S. | Pres, CEO | S - Sale | $182.94 | -14,059 | 164,979 | -8% | -$2,571,907 | ||||||
| D | 2025-11-03 | BSX | Boston Scientific Corp | Fitzgerald Joseph Michael | EVP, Group Pres, Cardiology | S - Sale+OE | $99.47 | -50,000 | 183,576 | -21% | -$4,973,338 | |||||
2025-11-03 | IRMD | Iradimed Corp | Susi Roger E. | CEO, Pres, COB, 10% | S - Sale | $82.64 | -5,000 | 4,547,950 | 0% | -$413,216 | ||||||
| D | 2025-11-03 | RMD | Resmed Inc | Sandercock Brett | CFO | S - Sale+OE | $247.54 | -3,000 | 85,745 | -3% | -$742,620 | |||||
2025-10-31 | IRTC | Irhythm Technologies, Inc. | Wilson Daniel G. | CFO | S - Sale | $207.44 | -8,000 | 26,570 | -23% | -$1,659,520 | ||||||
2025-10-31 | ATEC | Alphatec Holdings, Inc. | Hunsaker Craig E | EVP, PEOPLE, CULTURE | S - Sale | $19.95 | -100,000 | 1,289,142 | -7% | -$1,995,000 | ||||||
2025-10-30 | RVP | Retractable Technologies Inc | Shaw Thomas J | Pres, CEO, 10% | P - Purchase | $0.86 | +15,000 | 16,649,491 | 0% | +$12,915 | ||||||
| D | 2025-10-29 | MMM | 3M Co | Murphy Mark W. | EVP, Chief Info Digital Off | S - Sale+OE | $166.55 | -19,061 | 6,594 | -74% | -$3,174,589 | |||||
2025-10-28 | RVP | Retractable Technologies Inc | Shaw Thomas J | Pres, CEO, 10% | P - Purchase | $0.92 | +35,000 | 16,634,491 | 0% | +$32,029 | ||||||
2025-10-27 | IRMD | Iradimed Corp | Susi Roger E. | CEO, Pres, COB, 10% | S - Sale | $77.69 | -5,000 | 4,552,950 | 0% | -$388,429 | ||||||
| M | 2025-10-27 | BSX | Boston Scientific Corp | Zane Ellen M | Dir | S - Sale | $101.38 | -12,891 | 24,134 | -35% | -$1,306,900 | |||||
2025-10-24 | ATEC | Alphatec Holdings, Inc. | Sponsel David | EVP, Sales | S - Sale | $16.18 | -70,000 | 461,861 | -13% | -$1,132,600 | ||||||
2025-10-27 | RVP | Retractable Technologies Inc | Shaw Thomas J | Pres, CEO, 10% | P - Purchase | $0.94 | +34,506 | 16,599,491 | 0% | +$32,522 | ||||||
2025-10-27 | BDX | Becton Dickinson & Co | Feld Michael | EVP, Pres, Life Sciences | S - Sale | $186.01 | -57 | 8,245 | -1% | -$10,603 | ||||||
2025-10-23 | RVP | Retractable Technologies Inc | Shaw Thomas J | Pres, CEO, 10% | P - Purchase | $0.95 | +356 | 16,564,985 | 0% | +$339 | ||||||
| M | 2025-09-30 | GIPL | Global Innovative Platforms Inc. | Brown Andrew Nicholas | CEO, CFO, 10% | P - Purchase | $0.00 | +10,088,888 | 6,775,486 | -304% | +$6,459 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |